Head and neck pathology is challenging given the broad diversity of entities that are part of the functional (rather than simply theoretical) vocabulary at these sites. With the beta releases of the 5th editions of both the Head and Neck and Endocrine World Health Organization (WHO) Classifications of Tumors in 2022, several new concepts and entities have arisen and still remain challenging. Furthermore, since the publication of WHO 5th edition, several provisional entities and concepts have emerged making it difficult to adapt these new changes into practice. Through this course, the participants will learn diagnostic features, practical reporting, key prognostic, and theragnostic information for a variety of new and uncommon tumor types spanning several head and neck and endocrine sites. This course is a collaboration between the North American Society of Head and Neck Pathology (NASHNP) and USCAP.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Specialties served/covered
- Anatomic & Clinical Pathology
- Breast Imaging
- Cytopathology
- Dermatopathology
- Endocrinology, Diabetes & Metabolism
- General Surgery
- Head & Neck Surgery
- Hematology
- Hematopathology
- Musculoskeletal Oncology
- Nephrology
- Neuropathology
- Obstetrics & Gynecology
- Patient Safety & Quality Improvement
- Pediatric Pathology
- Urology
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Medical Subspecialties
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pathology & Lab
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.



